Cargando…

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases

BACKGROUND: Gallstones and kidney stones are known complications of inflammatory bowel diseases (IBD). Risk factors have been insufficiently studied and explanatory studies date back up to 30 years. It remains unclear, whether improved treatment options also influenced risk factors for these complic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagagnini, Stefania, Heinrich, Henriette, Rossel, Jean-Benoît, Biedermann, Luc, Frei, Pascal, Zeitz, Jonas, Spalinger, Marianne, Battegay, Edouard, Zimmerli, Lukas, Vavricka, Stephan R., Rogler, Gerhard, Scharl, Michael, Misselwitz, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638235/ https://www.ncbi.nlm.nih.gov/pubmed/29023532 http://dx.doi.org/10.1371/journal.pone.0185193

Ejemplares similares

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
por: Spalinger, Marianne R., et al.
Publicado: (2016)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Biedermann, Luc, et al.
Publicado: (2019)

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis
por: Roth, Sofia, et al.
Publicado: (2016)

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
por: Yoganathan, Priyatharsan, et al.
Publicado: (2021)

Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey
por: Barthel, Christiane, et al.
Publicado: (2015)

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
por: Yilmaz, Bahtiyar, et al.
Publicado: (2018)

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account
por: Zeitz, Jonas, et al.
Publicado: (2016)

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
por: Ledergerber, Martina, et al.
Publicado: (2021)

Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy
por: Spalinger, Marianne R., et al.
Publicado: (2013)

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Roth, Nina, et al.
Publicado: (2019)

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients
por: Greuter, Thomas, et al.
Publicado: (2018)

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort
por: Ditrich, Felicitas, et al.
Publicado: (2020)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Vavricka, Stephan R., et al.
Publicado: (2015)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Because I’m happy – positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort study
por: Lang, Brian M., et al.
Publicado: (2023)

Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015)

Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines
por: Looser, Rahel, et al.
Publicado: (2023)

Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
por: Siebenhüner, Alexander R., et al.
Publicado: (2021)

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors
por: Zeitz, Jonas, et al.
Publicado: (2015)

Perianal fistulodesis – A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae
por: Villiger, Roxanne, et al.
Publicado: (2021)

Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease
por: Scharl, Michael, et al.
Publicado: (2010)

Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans
por: Biedermann, Luc, et al.
Publicado: (2013)

Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study
por: Vavricka, Stephan, et al.
Publicado: (2017)

Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab
por: Wojtal, Kacper A., et al.
Publicado: (2012)

The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
por: Tcymbarevich, Irina V., et al.
Publicado: (2019)

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development
por: Lutz, C., et al.
Publicado: (2017)

Microbiota stability in healthy individuals after single-dose lactulose challenge—A randomized controlled study
por: Wotzka, Sandra Y., et al.
Publicado: (2018)

Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients
por: Bianchi, Rahel, et al.
Publicado: (2022)

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
por: Perrig, Kathrin, et al.
Publicado: (2022)

Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case–control study
por: Katsidzira, Leolin, et al.
Publicado: (2020)

PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner
por: Spalinger, Marianne R., et al.
Publicado: (2017)

Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs: Systematic Search for Clinical Practice Guidelines
por: Gutermann, Irit Kaye, et al.
Publicado: (2015)

PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
por: Spalinger, Marianne R., et al.
Publicado: (2018)

Activation of Protein Tyrosine Phosphatase Non-Receptor Type 2 by Spermidine Exerts Anti-Inflammatory Effects in Human THP-1 Monocytes and in a Mouse Model of Acute Colitis
por: Morón, Belén, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2h3mmcitni7po0v5jratef7tu0